Increased cardiac sympathetic drive and reduced vagal modulation following endothelin receptor antagonism in healthy conscious rats

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 7, 2008, Pages 751-756

  Souza, Hugo C D ^a   Terzini, Geisa C S V ^a   Da Silva, Valdo J D ^b   Martins Pinge, Marli C ^c   Salgado, Helio C ^a   Salgado, Maria Cristina O ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Triangulo Mineiro Federal University   (Brazil)

^c UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Autonomic nervous system; Baroreflex; Bosentan; Endothelin; Heart rate variability

Indexed keywords

BOSENTAN; ENDOTHELIN RECEPTOR; GUM ARABIC; METHYLATROPINE; PROPRANOLOL DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BRADYCARDIA; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; DRUG MECHANISM; HEART RATE; MALE; NONHUMAN; OSCILLATION; PRESSORECEPTOR REFLEX; RAT;

ANIMALS; BAROREFLEX; HEART RATE; MALE; RATS; RATS, WISTAR; RECEPTORS, ENDOTHELIN; SINOATRIAL NODE; SULFONAMIDES; SYMPATHETIC NERVOUS SYSTEM; VAGUS NERVE;

EID: 44349148485     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.04866.x     Document Type: Article

References (41)

1. Yanagisawa M, Kurihara H, Kimura S, Tomore Y, Kobayashi N, Mitsui Y. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988 332 : 411 15.
2. Kido T, Sawamura T, Masaki T. The processing pathway of endothelin-1 production. J. Cardiovasc. Pharmacol. 1998 31 (Suppl. 1 S13 15.
3. Haynes WG, Webb DJ. Endothelin as a regulator of cardiovascular function in health and disease. J. Hypertens. 1998 16 : 1081 98.
4. Schiffrin EL. Endothelin and endothelin antagonists in hypertension. J. Hypertens. 1998 16 : 1891 5.
5. Vanhoutte PM. Say NO ET. J. Auton. Nerv. Syst. 2000 81 : 271 7.
6. Mulder P, Richard V, Thuillez C. Endothelin antagonism in experimental ischemic heart failure: Hemodynamic, structural and neurohumoral effects. Heart Fail. Rev. 2001 6 : 295 300.
7. A receptor blocker LU 135252 on cardiac remodeling and survival in a hypertensive rat model of chronic heart failure. Acta Pharmacol. Sin. 2006 27 : 1417 22.
8. Shimoyama H, Sabbah HN, Borzak S et al. Short-term hemodynamic effects of endothelin receptor blockade in dogs with chronic heart failure. Circulation 1996 94 : 779 85.
9. Provencher S, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension with bosentan: From pathophysiology to clinical evidence. Expert Opin. Pharmacother. 2005 6 : 1337 48.
10. Kelland NF, Webb DJ. Clinical trials of endothelin antagonists in heart failure: A question of dose? Exp. Biol. Med. 2006 231 : 696 9.
11. Fleisch M, Sutsch G, Yan XW et al. Systemic, pulmonary, and renal hemodynamic effects of endothelin ET(A/B)-receptor blockade in patients with maintained left ventricular function. J. Cardiovasc. Pharmacol. 2000 36 : 302 19.
12. B receptor blockade on renal function in conscious rats: Effects of renal denervation. J. Physiol. Pharmacol. 2004 55 : 381 9.
13. Lambert E, Lambert G, Fassot C, Friberg P, Elghozi J. Subarachnoid hemorrhage induced sympathoexcitation arises due to changes in endothelin and/or nitric oxide activity. Cardiac Res. 2000 45 : 1046 53.
14. Kuwaki T, Koshiya N, Takahashi H, Terui N, Kumada M. Modulatory effects of rat endothelin on central cardiovascular control in rats. Jpn. J. Physiol. 1990 40 : 97 116.
15. Itoh S, Van Den Buuse M. Sensitization of baroreceptor reflex by central endothelin in conscious rats. Am. J. Physiol. 1991 260 : H1106 12.
16. Chapleau MW, Hajduczok G, Abboud FM. Suppression of baroreceptor discharge by endothelin at high carotid sinus pressure. Am. J. Physiol. 1992 263 : R103 8.
17. Kannan H, Tanaka H, Ueta Y, Hayashida Y, Kunitake T, Yamashita H. Effects of centrally administered endothelin-3 on renal sympathetic nerve activity and renal blood flow in conscious rats. J. Auton. Nerv. Syst. 1994 49 : 105 13.
18. Mosqueda-Garcia R, Appalsamy M, Fernandez-Violante R, Hamakubo T. Modulatory effects of endothelin on baroreflex activation in the nucleus of the solitary tract. Eur. J. Pharmacol. 1998 19, 351 : 203 7.
19. Liu JL, Pliquett RU, Brewer E, Cornish KG, Shen YT, Zucker IH. Chronic endothelin-1 blockade reduces sympathetic nerve activity in rabbits with heart failure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001 280 : R1906 13.
20. Tsuchiyama Y, Kasamatsu K, Hano T, Nishio I. Acute effect of endothelin AB antagonist on sympathetic outflow in conscious rats with heart failure. Circ. J. 2002 66 : 841 5.
21. Lu Y, Wang WZ, Liao Z, Yan XH, Tang CS, Yuan WJ. Blood pressure responses of endothelin-1 1-31 within the rostral ventrolateral medulla through conversion to endothelin-1 1-21. J. Cardiovasc. Pharmacol. 2005 46 : 823 9.
22. Clozel M, Breu V, Gray GA et al. Pharmacological characterization of bosentan, a new potent orally active non peptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther. 1994 270 : 228 35.
23. Coleman TG. Arterial baroreflex control of heart rate in the conscious rats. Am. J. Physiol. 1980 238 : H515 20.
24. Goldberger JJ. Sympathovagal balance. How should we measure it? Am. J. Physiol. 1999 276 : H1273 80.
25. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Circulation 1996 93 : 1043 65.
26. Rubini R, Porta A, Baselli G, Cerutti S, Paro M. Power spectrum analysis of cardiovascular variability monitored by telemetry in conscious unrestrained rats. J. Auton. Nerv. Syst. 1993 45 : 181 90.
27. Li DP, He RR. Intracarotid injection of endothelin-1 facilitates the activity of rostral ventrolateral medullary neurons via area postrema in rats. Sheng Li Xue Bao 1999 51 : 263 71.
28. Dai SM, Shan ZZ, Miao CY, Yin M, Su DF. Hemodynamic responses to endothelin-1 and endothelin antagonists microinjected into the nucleus tractus solitarius in rats. J. Cardiovasc. Pharmacol. 1997 30 : 475 80.
29. Shihara M, Hirooka Y, Hori N et al. Endothelin-1 increases the neuronal activity and augments the responses to glutamate in the NTS. Am. J. Physiol. 1998 275 : R658 65.
30. Hirooka Y, Shihara M, Eshima K, Hori N, Takeshita A. Endothelin-1 facilitates synaptic transmission in the nucleus tractus solitarii in normotensive rats but not in spontaneously hypertensive rats. Hypertens. Res. 1999 22 : 43 8.
31. Shihara M, Hirooka Y, Eshima K, Hori N, Takeshita A. Stimulatory effect of endothelin-1 on neurons in the nucleus tractus solitarii is mediated by non-N-methyl-d-aspartate receptors. Hypertens. Res. 2001 24 : 137 42.
32. Cao WH, Kuwaki T, Unekawa M, Ling GY, Terui N, Kumada M. Action of endothelin-1 on vasomotor neurons in rat rostral ventrolateral medulla. J. Cardiovasc. Pharmacol. 1993 22 (Suppl. 8 S196 8.
33. Yang XL, Fu WJ, Hou GX, Chen JG. Effect of endothelin-1 injected into rostral ventrolateral medulla on cardiovascular responses in cats. Zhongguo Yao Li Xue Bao 1999 20 : 566 70 (in Chinese).
34. Kumada M, Cao W, Kuwaki T. Effect of endothelin on vasomotor and respiratory neurons in the rostral ventrolateral medulla in rats. Cell Mol. Neurobiol. 2003 23 : 691 707.
35. Japundzic N, Grichois ML, Zitoun P, Laude D, Elghozi JL. Spectral analysis of blood pressure and heart rate in conscious rats: Effects of autonomic blockers. J. Auton. Neuv. Syst. 1990 30 : 91 100.
36. Elghozi JL, Japundzic N, Grichois ML, Zitoun P. Nervous mechanisms of spontaneous oscillations of systolic blood pressure and heart rate. Arch. Mal. Coeur. Vaiss. 1990 83 : 1065 8 (in French).
37. Nafz B, Wagner CD, Persson PB. Endogenous nitric oxide buffers blood pressure variability between 0.2 and 0.6 Hz in the conscious rat. Am. J. Physiol. 1997 272 : H632 7.
38. B receptors in regulation of cardiac contractile function in mice. Am. J. Physiol. Heart Circ. Physiol. 2003 285 : H112 18.
39. Goraca A. Negative chronotropic effect of endothelin-1 (ET-1) in the cardiac pacemaker tissue. J. Physiol. Pharmacol. 2003 54 : 53 63.
40. Michel MC, Li Y, Heusch G. Mitogen-activated protein kinases in the heart. Naunyn Schmiedebergs Arch. Pharmacol. 2001 363 : 245 66.
41. Peters SL, Sand C, Michel MC, Pfaffendorf M, Zwieten PA. A mitogen-activated protein kinase is involved in the inotropic but not chronotropic actions of adrenoceptor agonists and endothelin-1. Naunyn Schmiedebergs Arch. Pharmacol. 2002 366 : 189 91.